Fibrocell and Hefei Meifu Announce JV
November 05, 2010 at 09:37 AM EDT
Fibrocell Science, Inc. will set up a joint venture with Hefei Meifu Bio-Tech Limited, centered on developing its autologous fibroblast therapies for aesthetic use in Asia, excluding Japan. Fibrocell will contribute its fibroblast IP, clinical data and manufacturing processes. Meifu will build a manufacturing facility in Hefei and be responsible for commercialization and marketing. Further financial details were not disclosed. More details.... Stock Symbol: (OTCBB: FCSC)